Brief: Exelixis And Arcus Biosciences Announce Clinical Trial Collaboration To Evaluate Advanced Renal Cell Carcinoma Drug
04/12/2023 13:21
Dec 4 (Reuters) - Exelixis Inc EXEL.O :
* EXELIXIS AND ARCUS BIOSCIENCES ANNOUNCE CLINICAL TRIAL
COLLABORATION TO EVALUATE ZANZALINTINIB IN COMBINATION WITH
AB521 IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA
* ARCUS BIOSCIENCES INC: PHASE 1B/2 CLINICAL TRIAL EXPECTED
TO
BEGIN ENROLLING PATIENTS BEFORE YEAR-END 2023
Source text for Eikon: ID:nBw6QyxFYa
Further company coverage: EXEL.O
((reuters.briefs@thomsonreuters.com;))